Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-24

Clinical Trial Update: Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclophosphamide, doxorubicin, vincristine, and prednisone with or without gemcitabine in patients with previously untreated aggressive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Doxorubicin (doxorubicin)
  • Gemcitabine (Gemcitabine)
  • PREDNISONE (Prednisone)
  • Vincristine (vincristine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lymphoma, Small Intestine Cancer | Phase 2 | Status: COMPLETED